The company employs three approaches: direct investments, fund investments, and technical assistance, all designed to help scale promising solutions that can generate measurable impact.
This strategic move, first announced in February 2025, followed the signing of a definitive agreement between the two companies.
The announcement was made in a filing with the US Securities and Exchange Commission on May 27.
Construction is scheduled to begin this fall, with operations expected to start in 2027.
The Swedish company received EU funding to set up large-scale fermentation plant. The new site will produce binder-free, oat-based protein using mycelium.